Company Performance Metrics
TocopheRx is focused on developing innovative medicines that reduce the stress of infertility treatments for couples desiring to achieve the family plans. Their disruptive technology is a small molecule that combines the activity of both hormones used to treat infertility into a single molecule that will be delivered in a tablet to treat the
infertile partner in a couple, whether it is the woman or the man.
The most significant trend affecting the fertility of both women and men is postponement of child-bearing until careers have been established. Whether your decision relies on banking oocytes for the right partner, freezing embryos for future implantation, or treatment now to address current fertility problems, an orally active treatment regimen can be less stressful for both partners.
